Board
Stephanie O’brien
Board
Morningside
Ventures
Extensive Director experience of novel science companies
Guillaume Stewart-Jones
CEO/CSO
Inventor of many viral vaccines, including SARS-CoV-2, RSV etc.
Moderna, NIH, Oxford Uni.
Ken Kelley
Chair
45 Startups, many to IPO & M&A
Stephanie O’brien
Board
Morningside
Ventures
Extensive Director experience of novel science companies
Guillaume Stewart-Jones
CEO/CSO
Inventor of many viral vaccines, including SARS-CoV-2, RSV etc.
Moderna, NIH, Oxford Uni.
Ken Kelley
Chair
45 Startups, many to IPO & M&A